Lluis Cecchini

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer.

Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: November 08, 2024

Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer.

Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer.

Journal: Virchows Archiv : an international journal of pathology

Published: July 26, 2023

Sentinel Lymph Node Biopsy in Prostate Cancer Patients: Results From an Injection Technique Targeting the Index Lesion in the Prostate Gland.

Sentinel Lymph Node Biopsy in Prostate Cancer Patients: Results From an Injection Technique Targeting the Index Lesion in the Prostate Gland.

Journal: Frontiers in medicine

Published: April 29, 2022

Prostate cancer genetic propensity risk score may modify the association between this tumour and type 2 diabetes mellitus (MCC-Spain study).

Prostate cancer genetic propensity risk score may modify the association between this tumour and type 2 diabetes mellitus (MCC-Spain study).

Journal: Prostate cancer and prostatic diseases

Published: April 18, 2021

SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence.

SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence.

Journal: The Prostate

Published: December 11, 2020

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer.

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer.

Journal: Genome medicine

Published: August 07, 2020

Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome.

Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome.

Journal: Virchows Archiv : an international journal of pathology

Published: January 17, 2019

SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.

SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.

Journal: The Prostate

Published: January 07, 2019

Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status.

Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status.

Journal: Virchows Archiv : an international journal of pathology

Published: December 27, 2018

Structural differences in the diaphragm of patients following controlled vs assisted and spontaneous mechanical ventilation.

Structural differences in the diaphragm of patients following controlled vs assisted and spontaneous mechanical ventilation.

Journal: Intensive care medicine

Published: October 21, 2018

Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer.

Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer.

Journal: Proteomics. Clinical applications

Published: September 13, 2018

Micronuclei frequency in urothelial cells of bladder cancer patients, as a biomarker of prognosis.

Micronuclei frequency in urothelial cells of bladder cancer patients, as a biomarker of prognosis.

Journal: Environmental and molecular mutagenesis

Published: April 10, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026